Search Results for: svf

Recommended reads: gov scientists fear Trump 2nd term, MYCT1 in HSCs, in vivo editing

Trump

I’ve only met one scientist who was openly a Trump fan, but I’m sure there are more out there. Still, it seems most scientists are no fans of the former president. A new WaPo piece highlights how federal scientists are worrying about a possible second term for the former president. Government scientists & a second […]

Recommended reads: gov scientists fear Trump 2nd term, MYCT1 in HSCs, in vivo editing Read More »

Weekly reads: diabetes, GvHD, Novo Nordisk & regenerative medicine, HDACs

mesenchymal cells

Do many in the regenerative medicine field have favorite types of stem cells? Some seem to think there’s a tension between those working on pluripotent stem cells like iPS cells and those working with MSCs. I don’t see it that way, though. Whatever stem cells work best for a particular condition should be used and,

Weekly reads: diabetes, GvHD, Novo Nordisk & regenerative medicine, HDACs Read More »

9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging?

Cell Surgical Nework

I was able to watch some of the 9th Circuit Court hearing today on the FDA appeal of its loss in the Cell Surgical Network lawsuit. This post is my brief impressions as a scientist. What went down? Do the three judges seem to be leaning one way or another? The ruling in this case

9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging? Read More »

Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit

Symptoms_of_multiple_sclerosis

There has been a steady stream of encouraging data on stem cells for MS. Particularly for certain kinds of MS. A new study adds to this upbeat direction. Good news on stem cells for MS Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study, Journal of Neurology, Neurosurgery,

Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit Read More »

Burst Biologics unapproved biologic used by Weill Cornell: was there a cover-up?

Burst Biologics, Christopher Jones

The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers. The story also bears on the doctors and hospitals like Weill Cornell that were or are customers of the suppliers. Further, what is the FDA’s role in all of this? The

Burst Biologics unapproved biologic used by Weill Cornell: was there a cover-up? Read More »

Suit against Dr. Alvaro Skupin & Dra Nancy Alvarez over blinding at clinic is settled

Dra Nancy Alvarez, Alvaro Skupin

A patient who got scientifically unproven and non-FDA-approved stem cells from Dr. Alvaro Skupin, filed suited against him, his wife who is often known as Doctora Nancy or Dra Nancy Alvarez, and associated businesses. These firms include the stem cell clinic known as Mother Stem Cell Institute in Florida, where the injections apparently took place.

Suit against Dr. Alvaro Skupin & Dra Nancy Alvarez over blinding at clinic is settled Read More »

Goldwater Institute weighs in against FDA on Cell Surgical Network lawsuit appeal

Elliot Lander, Cell Surgical Network

An important appeals case is pending not just for the defendants Cell Surgical Network, et al., but also for the FDA. It could impact the stem cell field very broadly too. Cell Surgical Network lawsuit status Hopefully, we’ll get a decision before the end of this year. Cell Surgical Network is a large chain of

Goldwater Institute weighs in against FDA on Cell Surgical Network lawsuit appeal Read More »

Did US Stem Cell Clinic defy FDA injunction? New injured patient suit sparks questions

Dr. Antonio E Blanco MD, US Stem Cell

It feels like I’ve been writing about the Florida clinic US Stem Cell for a very long time. The FDA has been aware of them for about as long. It was only after reports of patient injuries that the FDA at last took action on US Stem Cell and its subsidiary US Stem Cell Clinic. Several

Did US Stem Cell Clinic defy FDA injunction? New injured patient suit sparks questions Read More »

FDA appeals Cell Surgical Network lawsuit verdict

Cell Surgical Network stem cell clinic chain

The FDA has finally filed an appeal of the Cell Surgical Network lawsuit verdict.  It took them a very long time for some reason. The stem cell clinic chain Cell Surgical Network and other defendants had prevailed in a federal district court here in California in front of Judge Jesus Bernal. Their adipose cell product, stromal

FDA appeals Cell Surgical Network lawsuit verdict Read More »